- Research works
- 23 ▼ 35% vs 2013–17
- Citations
- 127 5.4 per fractional work
- Top-10% rate
- 1.8% record average 16.5%
- Open access
- 25% world 28%
Not ranked overall: Pancreatic Cancer Action is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 3.9×. Every wedge is a field page.
Which keywords describe research at Pancreatic Cancer Action?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Tumor Microenvironment, Chemotherapy, Neoadjuvant Therapy, Pancreatic Cancer, Surgical Complications, Inflammation and Cancer Therapy.
- Metabolism
- Assembly Planning
- NHS
- Gene Therapy
- Metastasis
- Aging
- Cancer
- Surgical Complications
- Neoadjuvant Therapy
- Tumor Microenvironment
- Immunotherapy
- Chemotherapy
- Pancreatic Cancer
- Inflammation
- Cancer Therapy
- COVID-19
- Public Health
- Healthcare Workers
- Primary Care
- Design for Manufacture
- Targeted Therapy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 21 words, with their numbers
- Immunotherapy5▲ 32×7 topics
- Tumor Microenvironment4▲ 55×4 topics
- Chemotherapy4▲ 23×5 topics
- Neoadjuvant Therapy4▲ 67×2 topics
- Pancreatic Cancer3▲ 123×1 topic
- Surgical Complications3▲ 199×1 topic
- Inflammation2▲ 4.1×11 topics
- Cancer1▲ 4.2×7 topics
- Cancer Therapy1▲ 9.3×5 topics
- Aging1▲ 10×3 topics
- COVID-191▲ 7.4×3 topics
- Metastasis1▲ 15×4 topics
- Public Health1▲ 3.9×2 topics
- Gene Therapy1▲ 18×3 topics
- Healthcare Workers1▲ 32×1 topic
- NHS1▲ 225×1 topic
- Primary Care1▲ 12×2 topics
- Assembly Planning1▲ 52×1 topic
- Design for Manufacture1▲ 52×1 topic
- Metabolism1▲ 6.8×3 topics
- Targeted Therapy1▲ 21×2 topics
Which research topics does Pancreatic Cancer Action publish most on?
By volume in 2022–2025: Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Economic and Financial Impacts of Cancer and Pancreatitis Pathology and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pancreatic and Hepatic Oncology Research Oncology 1 works
- 2 Cancer Genomics and Diagnostics Cancer Research 0 works
- 3 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 4 Pancreatitis Pathology and Treatment Surgery 0 works
- 5 Telemedicine and Telehealth Implementation Public Health, Environmental and Occupational Health 0 works
- 6 Mobile Health and mHealth Applications General Health Professions 0 works
- 7 Social Media in Health Education Health 0 works
- 8 Neuroendocrine Tumor Research Advances Epidemiology 0 works
- 9 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 0 works
- 10 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pancreatic Cancer Action's research output changed?
Output in 2018–2022 was 35% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bordon
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.